Company
About us
Our Team
Discoveries
Programs
Publications
Selected
All
ES
Contact Us
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
Correction to: The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies
Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties
A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection
Antibody- and T Cell-Dependent Responses Elicited by a SARS-CoV-2 Adenoviral-Based Vaccine in a Socially Vulnerable Cohort of Elderly Individuals
Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis
Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm
Galectins as potential therapeutic targets in STIs in the female genital tract
